Abstract:BACKGROUND Pulmonary arterial hypertension (PAH) is characterized by progressive increase of pulmonary vascular resistance and obliterative pulmonary vascular remodeling that result in right heart hypertrophy, failure and premature death. One of the hallmarks of PAH is vascular fibrosis, an excessive deposition of extracellular matrix components (most notably collagen) in the vessel wall, which has been shown to have an important role in the pathogenesis of severe vascular remodeling. Our goal is to gain a better understanding of the mechanisms underlying pulmonary vascular fibrosis seen in IPAH patients in order to identify potential new drug target(s) to inhibit pulmonary vascular fibrosis and thereby prevent/reverse vascular remodeling for treatment of PAH. METHODS Employing the mice with Tie2 Cre‐mediated deletion of Egln1 which encodes hypoxia‐inducible factor prolyl hydroxylase 2, PHD2 ( Egln1 Tie2Cre ), and double knockout mice with Tie2 Cre‐mediated genetic deletions of both Egln1 and Hif1a (EH1) or Egln1 and Hif2a (EH2), we studied the role of PHD2 deficiency and HIF activation in inducing pulmonary vascular fibrosis. Trichrome staining was used to quantify pulmonary vascular fibrosis. Quantitative RT‐PCR analysis and immunostaining were carried out to define the molecular mechanisms of vascular fibrosis associated with PAH in Egln1 Tie2Cre mice. RESULTS Similar to IPAH lungs, mice inactivated for PHD2 in endothelial cells exhibited obliterative vascular remodeling with massive collagen deposition in the vessel wall as observed in Figure 1A . There was however no marked increase of interstitial fibrosis in Egln1 Tie2 lungs. Intriguingly, pulmonary vascular fibrosis was inhibited by genetic deletion of HIF2α but not HIF1α, suggesting an important role of activation of HIF2α secondary to PHD2 deficiency in mediating pulmonary vascular fibrosis. Quantitative RT‐PCR analysis revealed a marked increase of fibrotic markers such as collagen 1α1, 1α2 and 3α1 in Egln1 Tie2Cre mouse lungs, which was inhibited in EH2 mouse lungs. Another important feature of vascular fibrosis is the presence of myofibroblasts, which are responsible for extracellular matrix (ECM) production and accumulation. Immunostaining demonstrated prominent expression of periostin, a marker for myofibroblasts in Egln1 Tie2Cre mouse lungs. The number of cells co‐stained with α‐smooth muscle actin and periostin was drastically increased in the vessel wall of Egln1 Tie2 mouse lungs. CONCLUSIONS Our results demonstrate that endothelial PHD2 deficiency and resultant activation of HIF2α are responsible for pulmonary vascular fibrosis in the newly discovered mouse model of PAH with obliterative vascular remodeling and progressive right heart failure. We also showed that in vivo PHD2 deletion increases the number of myofibroblasts in the vessel wall. These studies defined an unexpected role of PHD2 deficiency in the mechanisms of vascular fibrosis associated with severe PAH. Thus, targeting PHD2/HIF‐2α signaling is a promising strategy to reverse vascular fibrosis for treatment of severe PAH and promote survival.

Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension

Endothelial PHD2 Deficiency Induces Nitrative Stress Via Suppression of Caveolin-1 in Pulmonary Arterial Hypertension

Abstract 12497: Diminished Cavolin-1 Expression and Augmented Nitrative Stress Secondary to Prolyl-4 Hydroxylase 2 Deficiency Contribute to Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension

Diminished Cavolin-1 Expression And Augmented Nitrative Stress Secondary To Prolyl-4 Hydroxylase 2 Deficiency Contribute To Obliterative Vascular Remodeling And Severe Pulmonary Arterial Hypertension

Phd2 Deficiency Induces Obliterative Vascular Remodeling and Severe Pah Through Nitrative Stress and Caveolin-1 Downregulation

Increased Nitrosoglutathione Reductase Activity in Hypoxic Pulmonary Hypertension in Mice

Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α

Hif2 Alpha is Required for the Development of Pulmonary Vascular Fibrosis Associated with Pulmonary Arterial Hypertension

Abstract 12629: Endothelial Prolyl-4 Hydroxylase 2 Deletion Induces Cardiac Hypertrophy and Heart Failure Via Hypoxia Inducible Factor-2α Activation

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.

Abstract 17370: Activation of Endothelial GCN2 Kinase Contributes to Pulmonary Vascular Remodeling and Pulmonary Arterial Hypertension

Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α

Non-muscle myosin light chain promotes endothelial progenitor cells senescence and dysfunction in pulmonary hypertensive rats through up-regulation of NADPH oxidase

Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through KLF4 deacetylation

Loss of Endothelial HIF-Prolyl hydroxylase 2 (PHD2) Induces Cardiac Hypertrophy and Fibrosis

Abstract 196: DDAH1 Knockout Exacerbates Hypoxia-induced Pulmonary Arterial Hypertension in Mice

Endothelial Cell-Specific Prolyl Hydroxylase-2 Deficiency Augments Angiotensin II-Induced Arterial Stiffness and Cardiac Pericyte Recruitment in Mice

Abstract 15227: Egln1 Deficiency Induce Alveolar Macrophages Accumulation and Polarize Lung Interstitial Macrophages to a Pro-pah State Mediating Obliterative Pulmonary Vascular Remodeling and Severe PAH

Coordination Between NADPH Oxidase and Vascular Peroxidase 1 Promotes Dysfunctions of Endothelial Progenitor Cells in Hypoxia-Induced Pulmonary Hypertensive Rats.

Endothelial and Smooth Muscle Cell Interaction Via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension

CD133+Vascular Progenitor Cells Contribute to the Pathogenesis of PAH